Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Sleep Initiation and Maintenance Disorders 2Ovarian Neoplasms 1Lymphoma 1Leukemia, Myeloid, Acute 1Chronic Pain 1Anxiety Disorders 1

Interventions

venetoclax 91Azacitidine 75Cytarabine 68Specimen Handling 45fludarabine 44Biopsy 32Cyclophosphamide 29Daunorubicin 27fludarabine phosphate 25Injections 25Decitabine 25Idarubicin 24Busulfan 20Granulocyte Colony-Stimulating Factor 19Whole-Body Irradiation 18Mycophenolic Acid 18Tacrolimus 17Melphalan 17decitabine and cedazuridine drug combination 16gilteritinib 14Stem Cell Transplantation 14CPX-351 14Mitoxantrone 13Peripheral Blood Stem Cell Transplantation 11Magnetic Resonance Spectroscopy 11Filgrastim 11Etoposide 11Cladribine 11ivosidenib 10revumenib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Acute × Cognitive Behavioral Therapy × 90 days × Clear all
NCT03747757 2026-05-20

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡